| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.17 | 0.007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |